School of Nursing, Midwifery and Social Work, The University of Queensland, St Lucia, QLD, Australia.
Queensland Children's Hospital, Children's Health Queensland Hospital and Health Service, South Brisbane, QLD, Australia.
Pediatr Res. 2024 Jul;96(1):148-158. doi: 10.1038/s41390-023-03014-1. Epub 2024 Jan 11.
Invasive devices are widely used in healthcare settings; however, pediatric patients are especially vulnerable to invasive device-associated harm. This study aimed to explore invasive device utility, prevalence, harm, and clinical practice across three Australian pediatric tertiary hospitals.
In 2022-2023, a multi-center, observational, rolling-point-prevalence survey was conducted. Fifty-per-cent of inpatients were systemically sampled by random allocation. Patients with devices were then followed for up to 3-days for device-related complications/failures and management/removal characteristics.
Of the 285 patients audited, 78.2% had an invasive device (n = 412 devices), with a median of 1 device-per-patient (interquartile range 1-2), with a maximum of 13 devices-per-patient. Over half of devices were vascular access devices (n = 223; 54.1%), followed by gastrointestinal devices (n = 112; 27.2%). The point-prevalence of all device complications on Day 0 was 10.7% (44/412 devices) and period-prevalence throughout the audit period was 27.7% (114/412 devices). The period-prevalence of device failure was 13.4% (55/412 devices).
The study highlighted a high prevalence of invasive devices among hospitalized patients. One-in-ten devices failed during the audit period. These findings underscore the need for vigilant monitoring and improved strategies to minimize complications and enhance the safety of invasive devices in pediatric hospital settings.
A high prevalence of invasive devices among hospitalized patients was reported. Of the 285 patients audited, almost 80% had an invasive device (total 412 devices), with a median of 1 device-per-patient and a maximum of 13 devices-per-patient. The most common devices used in pediatric healthcare are vascular access devices (n = 223; 54.1%), however, 16% (n = 36) of these devices failed, and one-third had complications. The point prevalence of all device complications at day 0 was 10.7% (44 out of 412 devices), with a period prevalence of 27.7% (114 out of 412 devices) throughout the audit period.
在医疗保健环境中，广泛使用了有创设备；然而，儿科患者尤其容易受到有创设备相关伤害。本研究旨在探索澳大利亚三家儿科三级医院的有创设备使用情况、流行率、危害和临床实践。
2022-2023 年，进行了一项多中心、观察性、滚动时点患病率调查。通过随机分配，对 50%的住院患者进行系统抽样。对有设备的患者进行了长达 3 天的随访，以了解设备相关并发症/故障以及管理/移除的特征。
在 285 名被审核的患者中，78.2%（n=412 个设备）有有创设备，中位数为 1 个设备/患者（四分位间距 1-2），最多有 13 个设备/患者。超过一半的设备是血管通路设备（n=223；54.1%），其次是胃肠道设备（n=112；27.2%）。在第 0 天所有设备并发症的时点患病率为 10.7%（44/412 个设备），整个审核期间的期间患病率为 27.7%（114/412 个设备）。设备故障的期间患病率为 13.4%（55/412 个设备）。
该研究强调了住院患者中有创设备的高患病率。在审核期间，十分之一的设备发生故障。这些发现突出表明，需要进行警惕性监测，并采取改进策略，以最大程度地减少并发症，并提高儿科医院环境中侵入性设备的安全性。
报告了住院患者中有创设备的高患病率。在被审核的 285 名患者中，近 80%（n=412 个设备）有有创设备，中位数为 1 个设备/患者，最多有 13 个设备/患者。儿科医疗保健中最常用的设备是血管通路设备（n=223；54.1%），然而，16%（n=36）的这些设备发生故障，三分之一的设备有并发症。在第 0 天所有设备并发症的时点患病率为 10.7%（44 个设备），在整个审核期间的期间患病率为 27.7%（114 个设备）。
Zotero 插件